115371 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39034)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22057)
  4. Surgery (21248)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15763)
  7. Center for Hematologic Malignancies (13263)
  8. Hematologic Malignancies, Division of (13087)
  9. Sloan Kettering Institute Postdocs (12936)
  10. Department of Pathology and Laboratory Medicine (12615)
Formats
  1. Journal Article (66748)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3742)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (661)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39034)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22057)
  4. Surgery (21248)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15763)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115371)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Oncology drug effectiveness from electronic health record data calibrated against RCT evidence: The PARSIFAL trial emulation
    Journal Article

    Merola, D.; Young, J.; Schrag, D.; Lin, K. J.; Robert, N.; Schneeweiss, S.
    Clinical Epidemiology (2022)

    Fulltext@MSK | Save
  • MAPK pathway genetic alterations are associated with prolonged overall survival in low-grade serous ovarian carcinoma
    Journal Article

    Manning-Geist, B.; Gordhandas, S.; Liu, Y. L.; Zhou, Q.; Iasonos, A.; Da Cruz Paula, A.; Mandelker, D.; Long Roche, K.; Zivanovic, O.; Maio, A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Microsatellite instability-high endometrial cancers with MLH1 promoter hypermethylation have distinct molecular and clinical profiles
    Journal Article

    Manning-Geist, B. L.; Liu, Y. L.; Devereaux, K. A.; Da Cruz Paula, A.; Zhou, Q. C.; Ma, W.; Selenica, P.; Ceyhan-Birsoy, O.; Moukarzel, L. A.; Hoang, T.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Improved efficacy of tafasitamab plus lenalidomide versus systemic therapies for relapsed/refractory DLBCL: RE-MIND2, an observational retrospective matched cohort study
    Journal Article

    Nowakowski, G. S.; Yoon, D. H.; Peters, A.; Mondello, P.; Joffe, E.; Fleury, I.; Greil, R.; Ku, M.; Marks, R.; Kim, K.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Enhancing radioiodine incorporation into radioiodine-refractory thyroid cancer with MAPK inhibition (ERRITI): A single-center prospective two-arm study
    Journal Article

    Weber, M.; Kersting, D.; Riemann, B.; Brandenburg, T.; Führer-Sakel, D.; Grünwald, F.; Kreissl, M. C.; Dralle, H.; Weber, F.; Schmid, K. W.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Transcriptomic correlates of tumor cell PD-L1 expression and response to nivolumab monotherapy in metastatic clear cell renal cell carcinoma
    Journal Article

    Denize, T.; Hou, Y.; Pignon, J. C.; Walton, E.; West, D. J.; Freeman, G. J.; Braun, D. A.; Wu, C. J.; Gupta, S.; Motzer, R. J.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Prevention and treatment of venous thromboembolism in primary and metastatic brain cancer
    Miscellaneous

    Zwicker, J.
    Clinical Advances in Hematology & Oncology (2022)

    Fulltext@MSK | Save
  • Adding umbralisib and ublituximab (U2) to ibrutinib in patients with CLL: A phase II study of an MRD-driven approach
    Journal Article

    Roeker, L. E.; Feldman, T. A.; Soumerai, J. D.; Falco, V.; Panton, G.; Dorsey, C.; Zelenetz, A. D.; Falchi, L.; Park, J. H.; Straus, D. J.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Synthesis of carbohydrate analogues of the THF-acetogenin 4-deoxyannomontacin and their cytotoxicity against human prostate cancer cell lines
    Journal Article

    Gonzalez Periche, P.; Ramdular, A.; Bhupathiraju, N. V. S. D. K.; Kalidindi, T.; Johnson, D. S.; Pillarsetty, N.; Mootoo, D. R.
    Carbohydrate Research (2022)

    Fulltext@MSK | Save
  • A nuclear cAMP microdomain suppresses tumor growth by Hippo pathway inactivation
    Journal Article

    Drozdz, M. M.; Doane, A. S.; Alkallas, R.; Desman, G.; Bareja, R.; Reilly, M.; Bang, J.; Yusupova, M.; You, J.; Eraslan, Z.; more...
    Cell Reports (2022)

    Fulltext@MSK | Save